Published by ChinaMNC · Jingdongyizu
Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials: A Guide for Foreign Founders
Yunnan Province has released its 15th Five-Year Plan for the Traditional Chinese Medicine (TCM) materials industry, outlining a strategic shift from volume to value. For foreign founders operating in China's health, cosmetics, or pharmaceutical sectors, this plan signals significant opportunities in high-quality cultivation, processing, and innovation. This article breaks down the key points from the official government notice and explains what they mean for your business.
Yunnan's New Direction for TCM Materials
Yunnan Province, a key region for traditional Chinese medicine (TCM) materials, has published its 15th Five-Year Plan for the industry. The plan sets a clear trajectory: by 2030, the cultivated area for TCM materials is expected to decrease by 1.608 million mu (approximately 107,200 hectares), while the comprehensive output value is targeted to increase by 50 billion RMB. This reflects a strategic shift from expanding quantity to enhancing quality, processing, branding, and overall efficiency. For foreign founders involved in health products, pharmaceuticals, or cosmetics, this plan outlines the regulatory and market environment you will be operating within.
Optimized Variety Layout: What to Grow
Building on the 156 varieties listed in the 2024 Yunnan Dao-di Medicinal Materials Catalogue, the plan focuses on three categories:
- Dao-di advantageous varieties: The "Top Ten Yunnan Medicines" represented by Panax notoginseng (Sanqi), including Paris polyphylla (Dian Chonglou), Erigeron breviscapus (Dengzhanhua), Dendrobium officinale (Tiepi Shihu), Amomum villosum (Sharen), Gastrodia elata (Tianma), Poria cocos (Yun Fuling), Angelica sinensis (Yun Danggui), Aucklandia lappa (Yun Muxiang), and Gentiana rigescens (Dian Longdan).
- Health-characteristic varieties: The "Top Ten Health Resources" such as Polygonatum kingianum (Dian Huangjing), Carthamus tinctorius (Honghua), Bletilla striata (Baiji), Dendrobium devonianum (Zipi Shihu), Phyllanthus emblica (Yu Ganzi), Coix lacryma-jobi (Yiyiren), Terminalia chebula (Hezi), Amomum tsaoko (Caoguo), ginger, and star anise.
- Potential cultivation varieties: The "Six Southern Medicines" including Sharen, Dragon's Blood (Longxuejie), Cibotium barometz (Gouji), Aquilaria sinensis (Chenxiang), Orthosiphon aristatus (Shencha), and Dai Bai Jie.
Foreign founders sourcing TCM materials should note these priority varieties, as they will likely receive greater government support and quality standards.
Accelerating Standardized Construction: How to Grow
The plan aims to establish 200 GAP (Good Agricultural Practice) bases for TCM materials. A key focus is achieving full GAP coverage for Wenshan Sanqi, while steadily advancing GAP bases for under-forest varieties such as Fuling, Sharen, Caoguo, and Huangbo (Phellodendron). The province also seeks to develop a number of national-level high-standard TCM raw material production bases. For foreign companies, GAP certification is increasingly important for ensuring supply chain quality and meeting international standards.
Under-Forest Cultivation: Where to Grow
Focusing on Dao-di herbs like Sanqi, Tianma, Fuling, Sharen, Huangjing, and Huangbo, the plan promotes under-forest cultivation and breeding. The area for ecological and under-forest planting bases is to expand to over 6 million mu. This approach aligns with sustainable sourcing trends and may offer opportunities for foreign investors in eco-friendly agriculture.
Primary Processing at Origin: Post-Harvest Handling
The plan supports establishing processing lines at the production sites of Dao-di herbs and high-standard raw material bases. It encourages linking GAP base materials with fresh-cut processing and upgrading products from primary raw materials to semi-industrial inputs. This presents opportunities for foreign firms in processing technology and equipment.
Developing High-Value-Added Products: Increasing Returns
Enterprises are encouraged to build modern deep-processing production lines and develop high-value-added products, creating a series of Yunnan medicine health products. The plan also promotes research and industrialization of health products such as daily cosmetics and functional health products. Foreign founders in the cosmetics or wellness sector may find partnership or investment opportunities here.
Preventing "Blind Expansion": Stabilizing the Market
For bulk varieties susceptible to market fluctuations, such as Sanqi, Danggui, and Chonglou, and scarce varieties, the plan emphasizes market-based adjustment mechanisms to smooth price volatility. An information monitoring and early-warning system will be established to guard against risks like "blind expansion" and "low prices hurting farmers." This is relevant for foreign buyers seeking stable supply and pricing.
Food-Medicine Homology Development: New Uses for Herbs
The plan includes developing standards for food-medicine homology raw materials and production processes. It aims to complete cross-border registration for 5–10 new products and plans to hold a "Yunnan Medicine Food-Medicine Homology Culture Festival." This indicates a push to expand into international markets, creating opportunities for foreign companies in product registration and cultural exchange.
"Yunnan Medicine Brain": Digital Intelligence
An artificial intelligence innovation project called "Yunnan Medicine Brain" will be implemented, building an intelligent application system covering the entire life cycle of TCM materials. This will drive multi-level, multi-scenario smart solutions in key areas. Foreign tech firms may find collaboration opportunities in this digital transformation.
Implications for Foreign Founders
For foreign founders registering or operating a company in China's TCM sector, Yunnan's plan offers a clear roadmap. The emphasis on quality, standardization, and high-value products aligns with international market demands. However, navigating China's regulatory landscape for agriculture, processing, and health products requires local expertise. Foreign investors should consider partnering with local entities or seeking professional guidance to leverage these opportunities effectively.
Call to Action: Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.